The U.S. Food and Drug Administration (FDA) has added restrictions to a drug study being done by GlaxoSmithKline. The study has been comparing two rival diabetes drugs-Avandia and Actos. Currently the study has at least 1,100 participants, and it looks as though this number will remain the same. However, Avandia has not yet issued a formal decision on the drug's safety.
The FDA began looking at the dangers of the drug in 2002. Physicians and researchers were concerned about the increase in heart attacks in users of the drug. So far the FDA has issued more specific and prominent warnings and has called off a large clinical trial of the drug.
If a spouse or parent has suffered a heart attack and died while taking Avandia, there may be something you can do. Please contact your Wisconsin, Illinois and Iowa pharmaceutical class action attorney at Hupy & Abraham today for your free consultation.